4c1a7c739d29ae8fbdb3cccaba9a4b68

ANTI-JKA (MONOCLONAL) MARCAS: GAMMA-CLONE, IMMUCOR GAMMA

IMMUCOR INC.·III·Colombia INVIMA·Expires May 26, 2027

Device classification

Risk class / Clase de Riesgo: III
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 4c1a7c739d29ae8fbdb3cccaba9a4b68
Expire date: May 26, 2027

Authorized company / Fabricante

Name (Spanish): IMMUCOR INC.
Name (English): IMMUCOR INC.

Product use / Uso del Producto

Spanish

ESTÁ INDICADO PARA LA DETECCIÓN DE LOS ANTÍGENOS _x000D_ JKA (JK1), EN HEMATÍES, MEDIANTE PRUEBAS EN TUBOS Y _x000D_ MICROPLACAS.

English

IT IS INDICATED FOR THE DETECTION OF ANTIGENS _x000D_ JKA (JK1), IN RED BLOOD CELLS, BY TUBE AND _x000D_ TESTS MICROPLATES.

About this record

Access comprehensive regulatory information for ANTI-JKA (MONOCLONAL) MARCAS: GAMMA-CLONE, IMMUCOR GAMMA (ANTI-JKA (MONOCLONAL) MARCAS: GAMMA-CLONE, IMMUCOR GAMMA ) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 4c1a7c739d29ae8fbdb3cccaba9a4b68 and manufactured by IMMUCOR INC.. The device was registered on May 26, 2027.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.